BioLargo, Inc. ( BLGO) - Key Metrics
BLGO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q1 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q3 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2025Q2 | $0.01 | $0 | -$0.01 | -$0.01 |
BLGO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -3.14% | -2.84 |
| 2026Q1 | -3.76% | -5.63 |
| 2025Q4 | -2.84% | -4.90 |
| 2025Q3 | -4.00% | -2.12 |
| 2025Q2 | 0% | -13.20 |
BLGO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -8.30% | 0.24% |
| 2026Q1 | -5.71% | 0.17% |
| 2025Q4 | -2.83% | 0.15% |
| 2025Q3 | -5.33% | 0.49% |
| 2025Q2 | -3.39% | 0% |
BLGO
Price: $0.07
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.04 USD
P/E Ratio: -4.50
Exchange: OQX
Sector: Basic Materials
Industry: Chemicals
Market Capitalization: 25.0 million